| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |